Abstract:Background Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. In recent years, continuous discoveries of new ALS-causing genes have enhanced the understanding of the genotype–phenotype relationship in ALS, aiding in disease progression prediction and providing a more comprehensive basis for genetic diagnosis. Methods A total of 1672 ALS patients who visited the Neurology Department of Peking Union Medical College Hospital between January 2014 and December 2022 and met the revised El Escorial diagnostic criteria were included. Clinical data were collected, whole exome sequencing and dynamic mutation screening of the C9ORF72 gene were performed, and the clinical phenotypes and genotypes of the patients were analyzed. Results The average age of onset for the 1672 ALS patients was 52.6 ± 11.2 years (range 17–85 years), with a median disease duration of 14 months at the time of visit (interquartile range 9–24 months, range 2–204 months). The male to female ratio was 833:839. The patients included 297 (17.8%) with bulbar onset, 198 (11.8%) with flail arm/leg syndrome, 89 (5.3%) with familial ALS, and 52 (3.1%) with concomitant frontotemporal dementia (FTD). Pathogenic variants associated with ALS were detected in 175 patients (10.5% of the cohort), with the most common mutations being SOD1 , FUS , and ANXA11 . Among patients with familial ALS, 56.2% (50/89) had genetic mutations, compared to 7.9% (125/1583) in sporadic ALS cases. From the perspective of phenotype-genotype correlation, (1) In ALS-FTD patients, the most common genetic mutations were ANXA11 and C9ORF72 repeat expansions. Patients with flail arm/leg syndrome more frequently carried mutations in SOD1 , ANXA11 , and hnRNPA1 ; (2) Despite genetic heterogeneity, it was observed that mutations in FUS and NEK1 were more common in males, and patients with FUS mutations had a younger age of onset; mutations in SOD1 and SQSTM1 were more likely to present with lower limb onset. Conclusion This study provides comprehensive data on the genetic characteristics of ALS patients in China through large-scale clinical data and genetic analysis of 1672 cases. Differences in age of onset, onset site, and clinical phenotype among ALS patients with different genotypes can help clinicians better predict disease progression and provide a basis for precise diagnosis and individualized treatment.

Medical cost and healthcare utilization of amyotrophic lateral sclerosis in China: A cohort study based on hospital data from 2015 to 2018

Incidence and Prevalence of Amyotrophic Lateral Sclerosis in Urban China: a National Population-Based Study

Financial cost of amyotrophic lateral sclerosis: A case study

Epidemiology and factors predicting survival of amyotrophic lateral sclerosis in a large Chinese cohort

Amyotrophic Lateral Sclerosis in Beijing: Epidemiologic Features and Prognosis from 2010 to 2015

Age at Onset of Amyotrophic Lateral Sclerosis in China

Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis

Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China

Managed care considerations to improve health care utilization for patients with ALS

Clinical features of amyotrophic lateral sclerosis in south-west China

Using the Capture-Recapture Method to Estimate the Incidence of Amyotrophic Lateral Sclerosis in Beijing, China.

Prognostic Factors in ALS: a Comparison Between Germany and China

Clinical and genetic characteristics of 1672 cases of amyotrophic lateral sclerosis in China: a single-center retrospective study

The Predictors of Survival in Chinese Amyotrophic Lateral Sclerosis Patients.

Healthcare Utilization and Supportive Care Timing in South Korean People Living With Amyotrophic Lateral Sclerosis: A Single-Center Retrospective Study

ALS-plus Related Clinical and Genetic Study from China

Hypothalamic Subregion Abnormalities Are Related to Body Mass Index in Patients with Sporadic Amyotrophic Lateral Sclerosis.

The Epidemiology and Genetics of Amyotrophic Lateral Sclerosis in China

Multicentre, prospective registry study of amyotrophic lateral sclerosis in mainland China (CHALSR): study protocol

A multicenter study to evaluate the disease burden and health economics of inpatients with multiple sclerosis in China

Trends in the Clinical Features of Amyotrophic Lateral Sclerosis: A 14‐year Chinese Cohort Study